Insulet Corp. (PODD)
131.96
-2.72
(-2.02%)
USD |
NASDAQ |
Sep 11, 16:00
132.50
+0.54
(+0.41%)
After-Hours: 20:00
Insulet Market Cap : 9.152B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 9.152B |
| September 10, 2026 | 9.340B |
| September 09, 2026 | 9.565B |
| September 08, 2026 | 9.867B |
| September 04, 2026 | 10.23B |
| September 03, 2026 | 10.44B |
| September 02, 2026 | 10.27B |
| September 01, 2026 | 10.29B |
| August 31, 2026 | 10.31B |
| August 28, 2026 | 10.06B |
| August 27, 2026 | 9.946B |
| August 26, 2026 | 9.944B |
| August 25, 2026 | 9.921B |
| August 24, 2026 | 10.09B |
| August 21, 2026 | 10.28B |
| August 20, 2026 | 10.19B |
| August 19, 2026 | 10.51B |
| August 18, 2026 | 10.27B |
| August 17, 2026 | 9.688B |
| August 14, 2026 | 9.941B |
| August 13, 2026 | 10.16B |
| August 12, 2026 | 10.06B |
| August 11, 2026 | 10.04B |
| August 10, 2026 | 9.907B |
| August 07, 2026 | 9.790B |
| Date | Value |
|---|---|
| August 06, 2026 | 9.661B |
| August 05, 2026 | 9.242B |
| August 04, 2026 | 11.57B |
| August 03, 2026 | 11.77B |
| July 31, 2026 | 11.45B |
| July 30, 2026 | 11.48B |
| July 29, 2026 | 11.82B |
| July 28, 2026 | 11.60B |
| July 27, 2026 | 11.43B |
| July 24, 2026 | 11.31B |
| July 23, 2026 | 10.97B |
| July 22, 2026 | 11.01B |
| July 21, 2026 | 11.34B |
| July 20, 2026 | 11.59B |
| July 17, 2026 | 11.36B |
| July 16, 2026 | 11.39B |
| July 15, 2026 | 11.03B |
| July 14, 2026 | 11.02B |
| July 13, 2026 | 11.22B |
| July 10, 2026 | 11.17B |
| July 09, 2026 | 10.96B |
| July 08, 2026 | 10.91B |
| July 07, 2026 | 11.19B |
| July 06, 2026 | 11.07B |
| July 02, 2026 | 11.39B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DexCom, Inc. | 31.34B |
| Abbott Laboratories | 176.41B |
| Boston Scientific Corp. | 62.18B |
| PROCEPT BioRobotics Corp. | 1.167B |
| Globus Medical, Inc. | 9.960B |
Market Cap Related Metrics
| PE Ratio | 26.16 |
| PS Ratio | 3.035 |
| PEG Ratio | 0.4889 |
| Price to Book Value | 6.435 |
| Price to Free Cash Flow | 34.88 |
| Price | 131.96 |
| Earnings Yield | 3.82% |
| PEGY Ratio | 0.4889 |
| Operating PE Ratio | 17.99 |
| Normalized PE Ratio | 26.64 |